COPPELL, Texas--(BUSINESS WIRE)--Jun. 12, 2017--
Mannatech®,
Incorporated (NASDAQ: MTEX), a global health and wellness company
committed to transforming lives to make a better world, announced that
its shareholders passed all proposals put to a vote at the company’s
annual shareholder meeting (the “Meeting”) held Thursday, June 8, 2017.
Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the
Meeting and David Johnson, Mannatech’s Chief Financial Officer, spoke to
the shareholders sharing the company’s financial results for 2016 and
the first quarter of 2017.
There were 2,710,858 outstanding shares of Mannatech’s common stock as
of April 13, 2017 entitled to vote and 1,990,126 shares, or
approximately 73.4%, represented at the Meeting, either in person or by
proxy.
The following matters were submitted and voted upon at the Meeting:
1. Mannatech shareholders voted on the election of two individuals to
the Board of Directors as Class III Directors to hold office until 2020
as set forth below:
|
|
|
|
|
|
|
|
Name
|
|
Number of Shares
For
|
|
Number of Shares
Withheld
|
|
Broker
Non-Votes
|
|
Robert A. Toth
|
|
1,340,425
|
|
120,874
|
|
528,827
|
|
Linda K. Ferrell, Ph.D.
|
|
1,341,393
|
|
119,906
|
|
528,827
|
|
|
|
|
|
|
|
2. Mannatech shareholders voted to ratify the appointment of BDO USA,
LLP as our independent registered public accounting firm for the fiscal
year ended December 31, 2017 as set forth below:
|
|
|
|
|
|
|
|
Number of Shares
For
|
|
Number of Shares
Against
|
|
Number of Shares
Abstaining
|
|
Broker Non-Votes
|
|
1,914,711
|
|
69,208
|
|
6,207
|
|
0
|
|
|
|
|
|
|
|
3. Mannatech shareholders approved, on an advisory basis, the
compensation of the company’s named executive officers as set forth
below:
|
|
|
|
|
|
|
|
Number of Shares
For
|
|
Number of Shares
Against
|
|
Number of Shares
Abstaining
|
|
Broker
Non-Votes
|
|
1,429,152
|
|
28,616
|
|
3,531
|
|
528,827
|
|
|
|
|
|
|
|
4. Mannatech shareholders approved the company’s 2017 Stock Incentive
Plan as set forth below:
|
|
|
|
|
|
|
|
Number of Shares
For
|
|
Number of Shares
Against
|
|
Number of Shares
Abstaining
|
|
Broker
Non-Votes
|
|
1,421,349
|
|
36,682
|
|
3,268
|
|
528,827
|
|
|
|
|
|
|
|
To begin improving your life and the lives of those around you, please
visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, offers a profound wellness experience that
makes a difference in the lives of people across the world. Through its
innovative Glyconutrition products, Mannatech changes lives, providing
an unprecedented level of natural wellness, freedom and purpose. With
more than 20 years of experience and operations in 26 markets, Mannatech
is committed to changing lives. For more information, visit Mannatech.com.
Mannatech operates in China under a cross-border e-commerce platform
that is separate from its network marketing model.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170612005916/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Donna Giordano, 972-471-6512
ir@mannatech.com